STOCK TITAN
  1. Home
  2. News
  3. TIVC

Tivic Health Systems Inc - TIVC STOCK NEWS

Welcome to our dedicated page for Tivic Health Systems news (Ticker: TIVC), a resource for investors and traders seeking the latest updates and insights on Tivic Health Systems stock.

Tivic Health Systems, Inc. (NASDAQ: TIVC) is a pioneering health technology company dedicated to transforming bioelectronic medicine. Our core mission is to develop and commercialize non-invasive products that activate the body’s natural healing mechanisms. Headquartered in San Francisco, Tivic Health is at the forefront of delivering innovative solutions for therapeutic benefit, predominantly focusing on sinus pain relief.

Our flagship product, ClearUP Sinus Relief, is a patented handheld device designed to alleviate sinus pain and congestion using ultra-low electrical currents. This device offers a natural alternative to conventional treatments like nasal sprays, pills, and saline flushes, and is particularly beneficial for individuals suffering from nasal allergies, sinus infections, chronic sinusitis, and the common cold.

Our latest innovation, Synus, provides temporary relief from sinus pain and pressure through microcurrents. This product represents our commitment to offering non-pharmaceutical options to those seeking effective and convenient sinus pain management.

With an emphasis on safety and efficacy, Tivic Health is not only advancing bioelectronic medicine but also setting new standards in patient care. Our team of dedicated professionals continually explores the therapeutic potential of microcurrents, aiming to expand our product line to treat various medical conditions in the future. We are committed to enhancing the quality of life for our users by providing accessible and effective health solutions.

For the latest updates and developments, stay tuned to our Latest News section and follow our progress as we continue to innovate and grow in the exciting field of bioelectronic medicine.

News

Tivic Health Partners With InStep Health to Access Over 2,500 Healthcare Providers and Their Patients.

Rhea-AI Summary
Tivic Health has signed an agreement with InStep Health to introduce its bioelectronic sinus device, ClearUP, to over 2,500 healthcare providers and their patients. The 4-month program aims to educate HCPs and increase patient awareness of ClearUP during allergy, cold, and flu seasons. This could potentially lead to increased sales and recommendations for the product.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.49%
Tags
partnership
-
News

Tivic Health Systems, Inc. Regains Compliance With Nasdaq Listing Requirements

Rhea-AI Summary
Tivic Health has regained compliance with NASDAQ's minimum bid price requirement, ensuring continued listing and trading on the Nasdaq Capital Market.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.38%
Tags
none
-
News

Tivic Health Signs Agreement with AmerisourceBergen for Retail Pharmacy Customers

Rhea-AI Summary
Tivic Health has entered into a non-exclusive agreement with AmerisourceBergen to make its products available on AmerisourceBergen's third-party marketplace. Tivic's ClearUP bioelectronic sinus pain relief device will be offered on the marketplace, which aims to create a faster and more convenient shopping experience for retail pharmacy customers. This partnership is seen as a strategic step in expanding Tivic's customer reach and product awareness with independent retail pharmacies.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-11.01%
Tags
none
News

Tivic Health Systems, Inc. Announces Reverse Stock Split

Rhea-AI Summary
Tivic Health announces 1-for-100 reverse stock split effective August 23, 2023 to regain compliance with Nasdaq listing requirements.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-33.9%
Tags
none
-
News

Tivic Health Funded Study Begins Enrollment for Novel Non-Invasive Bioelectronic Approach to Vagus Nerve Stimulation

Rhea-AI Summary
Tivic Health® Systems, Inc. has received study approval for its bioelectronic device approach to vagus nerve stimulation.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
81.08%
Tags
none
-
News

Tivic Reports Second Quarter 2023 Financial Results

Rhea-AI Summary
Tivic Health announced Q2 2023 financial results. Gross profit increased to 37.5% from 23.4% in Q2 2022. Net loss decreased to $2.1 million from $3.0 million. Cash and cash equivalents totaled $2.7 million. Operating expenses reduced to $2.2 million from $3.1 million. Signed distribution agreement with Cardinal Health. Sold shares of common stock for $5.2 million. Shareholders voted for reverse stock split. Q2 revenue decreased by 70% to $161 thousand. Marketing expense reductions led to 82% decline in unit sales offset by 69% increase in average price per unit.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.5%
Tags
earnings
News

Tivic Health Reports Second Quarter 2023 Financial Results on August 14th Via Conference Call and Webcast

Rhea-AI Summary
Tivic Health Systems, Inc. (Nasdaq: TIVC) will report financial results for Q1 2023 on August 14th, 2023. The conference call and webcast will be pre-recorded and start at 1:30 pm PT / 4:30 pm ET. Shareholders can submit questions in advance until August 8th, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.89%
Tags
earnings
-
News

Tivic Health Announces Pricing of $1.4 Million Public Offering of Common Stock

Rhea-AI Summary
Tivic Health Systems, Inc. has announced the pricing of its public offering of 33,173,000 shares of common stock at a price of $0.041 per share. The gross proceeds from the offering are expected to be approximately $1.4 million. The net proceeds will be used for working capital and general corporate purposes. The offering is being facilitated by Maxim Group LLC as the sole placement agent.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-37.5%
Tags
offering
-
News

Tivic Health Announces Proposed Public Offering of Common Stock

Rhea-AI Summary
Tivic Health Systems, a health tech company, plans to offer and sell shares of its common stock in a public offering. The net proceeds will be used for working capital and general corporate purposes. The offering is subject to market conditions and there is no assurance on its completion or terms.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-37.5%
Tags
offering
News

Tivic Health Expands IP Protection with Issuance of Sixth Patent for its Bioelectronic Platform

Rhea-AI Summary
Tivic Health Systems, Inc. has received its sixth patent for its bioelectronic platform, expanding its intellectual property. The patent includes proprietary contacts, conductive circuitry design, and algorithms to optimize therapy delivery. The company has an additional 17 patents pending. Tivic's first commercial product, ClearUP, is an FDA-approved over-the-counter bioelectronic device for treating inflammation symptoms.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2%
Tags
none

FAQ

What is the current stock price of Tivic Health Systems (TIVC)?

The current stock price of Tivic Health Systems (TIVC) is $0.3251 as of March 3, 2025.

What is the market cap of Tivic Health Systems (TIVC)?

The market cap of Tivic Health Systems (TIVC) is approximately 3.7M.

What is Tivic Health Systems, Inc.?

Tivic Health Systems, Inc. is a health technology company focused on developing and commercializing non-invasive bioelectronic medicine.

What does Tivic Health specialize in?

Tivic Health specializes in using microcurrents to provide therapeutic benefits, particularly in relieving sinus pain and pressure.

What is the ClearUP Sinus Relief device?

ClearUP Sinus Relief is a patented handheld device that uses ultra-low current electrical waves to alleviate sinus pain and congestion.

How does Tivic Health's technology work?

Tivic Health's platform-based technology activates the body's natural healing mechanisms using non-invasive bioelectronic methods.

What conditions does ClearUP Sinus Relief treat?

ClearUP Sinus Relief treats nasal allergies, sinus infections, chronic sinusitis, cold and flu symptoms, and other sinus-related conditions.

What is Synus?

Synus is Tivic Health's new product that provides temporary relief from sinus pain and pressure through the use of microcurrents.

How is Tivic Health different from pharmaceutical companies?

Tivic Health provides natural alternatives to synthetic chemical treatments commonly used in pharmaceuticals, focusing on non-invasive bioelectronic medicine.

Where can I learn more about Tivic Health's products?

You can learn more about Tivic Health's products on their official website and through their latest news updates.

Why choose Tivic Health products?

Tivic Health products offer safe, effective, and non-invasive options for managing sinus pain without the need for pills, sprays, or flushes.

What are the future plans for Tivic Health?

Tivic Health plans to expand its product line, exploring the therapeutic potential of microcurrents for various other medical conditions.
Stock TIVC logo
Tivic Health Systems Inc

Nasdaq:TIVC

TIVC Rankings

N/A Ranked by Market Cap
N/A Ranked by Dividends
#53 Top Gainer

TIVC Stock Data

3.70M
10.40M
0.25%
3.64%
1.8%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States
FREMONT